Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation

Bibliographic Details
Main Authors:	Rhona Johnston, Olalekan Uthman, Ewen Cummins, Christine Clar, Pamela Royle, Jill Colquitt, Bee Kang Tan, Andrew Clegg, Saran Shantikumar, Rachel Court, J Paul O’Hare, David McGrane, Tim Holt, Norman Waugh
Format:	Article
Language:	English
Published:	NIHR Journals Library 2018-02-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta21020-c201802

Internet